and prurigo nodularis (firm bumps). Studies show people of color in the United States are more likely to develop atopic dermatitis and experience more severe symptoms compared to white people.

If you have a darker skin tone, you might see small, hardened, very itchy bumps, known as prurigo nodularis, on areas of your skin affected by atopic dermatitis. You may also be likely to get ...

SILVERBERG: Atopic dermatitis is a complex and heterogeneous ... the potential involvement of IL-31 in conditions like prurigo nodularis with emerging considerations for disorders such as ...

long-term therapeutic option for patients with atopic dermatitis and prurigo nodularis seeking relief from itch and skin lesions. We remain steadfast in our efforts to bring this potential ...

Nemolizumab “is also the first and only biologic approved for atopic dermatitis and prurigo nodularis with 4-week dosing intervals from the start of treatment,” according to the statement.

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is ...

In our JAK inhibitors session at the AAD, I discussed the role of JAK inhibitors in atopic dermatitis, prurigo nodularis, and also pruritus, or itch in general. For topical agents, we focused on ...

Dupixent (dupilumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as atopic dermatitis ... Dupixent is used to treat prurigo nodularis in adults.

showing that Nemluvio has the potential to address the significant unmet needs of patients with atopic dermatitis and prurigo nodularis 1-3 There is a need for new treatment options for atopic ...

9 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis, and fibrosis in prurigo nodularis.